Allogeneic HSCT with reduced intensity conditioning regimens in high risk patients with myelofibrosis

被引：0
|
作者：
Rondelli, D
Barosi, G
Bacigalupo, A
Prchal, JT
Popat, U
Alessandrino, EP
Spivak, JL
Hoffman, R
Fruchtman, S
机构：
[1] Univ Illinois, Chicago, IL 60680 USA
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
[3] Osped San Martino Genova, Genoa, Italy
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Johns Hopkins Univ, Baltimore, MD 21218 USA
[6] Mt Sinai Sch Med, New York, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2003.12.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Reduced-intensity allogeneic HSCT in patients with myeloid metaplasia with myelofibrosis
    Musso, M
    Porretto, F
    Crescimanno, A
    Polizzi, V
    Scalone, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S206 - S206
  • [2] Allogeneic HSCT with reduced intensity versus myeloablative conditioning regimens in paediatric acute lymphoblastic leukaemia
    Semenova, E.
    Stancheva, N.
    Kazantsev, I.
    Vasilieva, Y.
    Kostorov, V.
    Shiryaev, S.
    Afanasyev, B.
    Zubarovskaya, L.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S285 - S285
  • [3] Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens
    Merup, Mats
    Lazarevic, Vladimir
    Nahi, Hareth
    Andreasson, Bjorn
    Malm, Claes
    Nilsson, Lars
    Brune, Mats
    LeBlanc, Katarina
    Kutti, Jack
    Birgegard, Gunnar
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 367 - 373
  • [4] Is splenectomy necessary in patients with myelofibrosis and extensive splenomegaly prior to allogeneic stem cell transplantation with reduced intensity conditioning regimens?
    Ciurea, Stefan O.
    Sadegi, Barry
    Wilbur, Andrew
    Alagiozian-Angelova, Victoria
    Gaitonde, Sujata
    Dobogai, Lisa C.
    Akard, Luke P.
    Hoffman, Ronald
    Rondelli, Damiano
    BLOOD, 2007, 110 (11) : 331A - 331A
  • [5] Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
    Kim, Dong Hyun
    Seo, Jeongmin
    Shin, Dong-Yeop
    Koh, Youngil
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Byun, Ja Min
    BLOOD RESEARCH, 2022, 57 (04) : 264 - 271
  • [6] PSYCHOSOCIAL ADJUSTMENT IN LONG TERM SURVIVORS OF ALLOGENEIC HSCT: A COMPARISON OF PATIENTS TREATED WITH MYELOABLATIVE (MC) AND REDUCED INTENSITY CONDITIONING (RIC) REGIMENS
    Bevans, M.
    Mitchell, S.
    Wehrleu, L.
    Prachenko, O.
    Soeken, K.
    Koklanaris, E.
    Cook, L.
    Odom, J.
    Prince, P.
    Le, Q.
    Castro, K.
    Cusack, G.
    Savani, B.
    Fowler, D.
    Childs, R.
    Barrett, A. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 32 - 32
  • [7] Non-myeloablative allogeneic HSCT in high risk patients with myelofibrosis.
    Rondelli, D
    Barosi, G
    Bacigalupo, A
    Prchal, JT
    Popat, U
    Alessandrino, EP
    Spivak, JL
    Hoffman, R
    Fruchtman, S
    BLOOD, 2003, 102 (11) : 199A - 199A
  • [8] NONMYELOABLATIVE AND REDUCED INTENSITY CONDITIONING IN ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS
    Malone, A. K.
    Scigliano, E.
    Grosskreutz, C.
    Osman, K.
    Isola, L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S285 - S285
  • [9] Outcomes of sibling and unrelated donor reduced intensity conditioning allogeneic hsct for patients with MDS RCMD
    Krishnamurthy, P.
    Lim, Z. Y.
    Ho, A.
    Kenyon, M.
    Ceesay, M. M.
    Hayden, J.
    Ireland, R.
    Marsh, J.
    Mufti, G.
    Pagliuca, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S180 - S180
  • [10] SEQUENTIAL CHEMOTHERAPY FOLLOWED BY REDUCED INTENSITY CONDITIONING AND ALLOGENEIC HSCT FOR HIGH RISK AML PATIENTS IN FIRST COMPLETE REMISSION: A PROSPECTIVE PILOT STUDY
    Michallet, M.
    Sobh, M.
    Ducastelle, S.
    Gilis, L.
    Tigaud, I.
    Hayette, S.
    El-Hamri, M.
    Labussiere, H.
    Barraco, F.
    Nicolini, F. E.
    Thomas, X.
    HAEMATOLOGICA, 2014, 99 : 426 - 427
12345